Lipocine Inc. buy StockNews.com
Start price
21.09.24
/
50%
€3.67
Target price
21.09.25
-
Performance (%)
-
End price
22.09.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Lipocine Inc. | - | - | - |
| iShares Core DAX® | 3,02 % | 2,20 % | 14,66 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % | 31,41 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % | 49,42 % |
| iShares S&P 500 | 2,64 % | 1,01 % | 25,12 % |
Comments by StockNews_com for this prediction
In the thread Lipocine Inc diskutieren
Lipocine Inc. (NASDAQ: LPCN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for LPCN provided by MarketBeat
In the thread Trading Lipocine Inc
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten